Isomorphic Labs

#AI #AstraZeneca #Drug discovery #Isomorphic Labs #Pistoia Alliance

From the Editor: The steady shift to AI

It is especially difficult within the life sciences sector – and indeed everyday life – to avoid mentions of AI and the inevitable changes it will bring, and is bringing, to drug discovery.   Further difficulty stems from the need to distinguish between hype, reality and fantasy. Drug discovery and development is a… Read More

#Exclusive Content

#Artificial intelligence (AI) #Drug discovery #Fundraising #Isomorphic Labs

Isomorphic Labs raises $600m to support AI drug design

Isomorphic Labs has raised $600 million towards its ambition to leverage AI to reimagine and accelerate drug discovery.   The financing round was led by Thrive Capital, with participation from GV, and follow-on capital from existing investor Alphabet.  Isomorphic Labs aims to apply its AI drug design engine to deliver biomedical… Read More

#Business & Investment #News